43 Tumor mutational burden corrected for human leukocyte antigen somatic defects predicts response to checkpoint blockade in advanced non-small cell lung cancer
Biomarkers, Immune Monitoring and Novel Technologies
43 Tumor mutational burden corrected for human leukocyte antigen somatic defects predicts response to checkpoint blockade in advanced non-small cell lung cancer